>
VG Life Sciences Inc logo

VGLS - VG Life Sciences Inc Share Price

$0.003 -0.0  -12.1%

Last Trade - 17/09/21

Sector
Healthcare
Size
Micro Cap
Market Cap £1.57m
Enterprise Value £4.48m
Revenue £n/a
Position in Universe th / 7149
Bullish
Bearish
Unlock VGLS Revenue
Momentum
Relative Strength (%)
1m -11.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -88.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
0.000 0.006 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2015, VG LifeSciences Inc revenues was not reported. Net loss decreased33% to $3.9M. Lower net loss reflects Interest expensedecrease of 33% to $1.4M (expense), Legal and Professionaldecrease of 63% to $403K (expense), Research anddevelopment decrease of 53% to $463K (expense). BasicEarnings per Share excluding Extraordinary Items increasedfrom -$0.21 to -$0.06.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VGLS Revenue Unlock VGLS Revenue

Net Income

VGLS Net Income Unlock VGLS Revenue

Normalised EPS

VGLS Normalised EPS Unlock VGLS Revenue

PE Ratio Range

VGLS PE Ratio Range Unlock VGLS Revenue

Dividend Yield Range

VGLS Dividend Yield Range Unlock VGLS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
VGLS EPS Forecasts Unlock VGLS Revenue
Profile Summary

VG Life Sciences Inc. is a biotechnology company. The Company is engaged in developing transformative therapies to treat drug-resistant cancers, infectious diseases and autoimmune diseases caused by chronic inflammation. The Company operates as a drug discovery and development company researching two core technologies: Targeted Peptide Technology (TPT) and Metabolic Disruption Technology (MDT). The Company's MDT compounds impede tumor cells' ability to meet their energy requirements, leaving cancer cells vulnerable to cancer-killing agents. Its autoimmune therapy, TPT, eliminates a subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. Its peptides are designed to function in all Major Histocompatibility Complex II (MHC-II) phenotypes. It also has a drug research program in pre-clinical stages, a TPT therapy for human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) using VG1177.

Directors
Last Annual December 31st, 2014
Last Interim September 30th, 2015
Incorporated June 8, 1998
Public Since January 31, 2001
No. of Shareholders: n/a
No. of Employees: 7
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 744,019,303
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
VGLS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VGLS
Upcoming Events for VGLS
Frequently Asked Questions for VG Life Sciences Inc
What is the VG Life Sciences Inc share price?

As of 17/09/21, shares in VG Life Sciences Inc are trading at $0.003, giving the company a market capitalisation of £1.57m. This share price information is delayed by 15 minutes.

How has the VG Life Sciences Inc share price performed this year?

Shares in VG Life Sciences Inc are currently trading at $0.003 and the price has moved by -63.75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the VG Life Sciences Inc price has moved by -72.23% over the past year.

What are the analyst and broker recommendations for VG Life Sciences Inc?

Of the analysts with advisory recommendations for VG Life Sciences Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for VG Life Sciences Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will VG Life Sciences Inc next release its financial results?

VG Life Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-09-30
What is the VG Life Sciences Inc dividend yield?

VG Life Sciences Inc does not currently pay a dividend.

Does VG Life Sciences Inc pay a dividend?

VG Life Sciences Inc does not currently pay a dividend.

When does VG Life Sciences Inc next pay dividends?

VG Life Sciences Inc does not currently pay a dividend.

How do I buy VG Life Sciences Inc shares?

To buy shares in VG Life Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of VG Life Sciences Inc?

Shares in VG Life Sciences Inc are currently trading at $0.003, giving the company a market capitalisation of £1.57m.

Where are VG Life Sciences Inc shares listed? Where are VG Life Sciences Inc shares listed?

Here are the trading details for VG Life Sciences Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: VGLS
What kind of share is VG Life Sciences Inc?

We were not able to load our ranking data for VG Life Sciences Inc

Is there a VG Life Sciences Inc share price forecast 2021?

We were not able to load any forecast data for VG Life Sciences Inc.

How can I tell whether the VG Life Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VG Life Sciences Inc. Over the past six months, the relative strength of its shares against the market has been -69.43%. At the current price of $0.003, shares in VG Life Sciences Inc are trading at -56.7% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the VG Life Sciences Inc PE Ratio?

We were not able to find PE ratio data for VG Life Sciences Inc.

Who are the key directors of VG Life Sciences Inc?

VG Life Sciences Inc's management team is headed by:

Haig Keledjian - CHM
Arthur Keledjian - DRC
Who are the major shareholders of VG Life Sciences Inc?

Here are the top five shareholders of VG Life Sciences Inc based on the size of their shareholding:

Similar to VGLS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.